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Background: Gallstones appear more frequently in patients with cirrhosis and open cholecystectomy in
this patient population is associated with higher morbidity and mortality. The aim of the present study was
to evaluate experience with laparoscopic cholecystectomy in patients with cirrhosis and to provide
recommendations for management.
Methods: Retrospective review of laparoscopic cholecystectomy in patients with cirrhosis from March
1999 to May 2008 was performed. Peri-operative characteristics and subgroup analysis were performed
in patients with Child–Pugh's classes A, B and C cirrhosis.
Results: A total of 68 patients were reviewed in this study. In all, 69% of the patients were Child's class
A. The most common indication for cholecystectomy was chronic/symptomatic cholelithiasis (68%).
Compared with patients with Child's class B and C, laparoscopic cholecystectomy in patients with Child's
class A was associated with significantly decreased operative time (P = 0.01), blood loss (P = 0.001),
conversion to open cholecystectomy (P = 0.001) and length of hospital stay (P = 0.001).
Conclusions: Laparoscopic cholecystectomy in patients with cirrhosis is feasible with no mortality and
low morbidity, especially in patients with Child's class A cirrhosis.
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Introduction
Gallstones appear to occur more frequently in patients with cir-
rhosis compared with the non-cirrhotic population (23–79% vs.
7–23%, respectively).1–5 Open cholecystectomies in the cirrhotic
patient population are reported to have high mortality (from 8%
to as high as 83% in patients with a prothrombin time >2.5 s over
control) and morbidity (6.6–57%).6–9 In the late 1980s laparos-
copy was introduced, which eventually became the standard
approach for most cholecystectomies; however, the NIH con-
sensus statement in 1992 stated that end-stage cirrhosis was a
contraindication to laparoscopic cholecystectomy.10 Several series
have since suggested that laparoscopic cholecystectomy in patients
with cirrhosis is safe and associated with low mortality (0–4%)
and acceptable morbidity rates (0–52%).11–19
The present study is a retrospective review (1999–2008) of the
largest single institutional series reported in the United States.
The aim of the study was to evaluate the experience with laparo-
scopic cholecystectomy in patients with cirrhosis and to provide
practical recommendations for management.
Patients and methods
Between March 1999 and May 2008, a retrospective review of
all cholecystectomies performed by two surgeons (T.C.G. and
D.A.G.) at the UPMC Liver Cancer Center was performed.
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Patients who had underlying cirrhosis were included for further
analysis. All surgical procedures were performed at a single ter-
tiary level hospital.
Pre-operative characteristics gathered from the medical records
included age, gender, pre-operative laboratory values, Child–
Pugh’s classification at the time of surgery and indication for
cholecystectomy. Based on the documented laboratory values at
the time of surgery [albumin, total bilirubin and international
normalized ratio (INR)] and clinical presentation (ascites and
encephalopathy), the Child–Pugh’s score was calculated. Gall-
stone or biliary disease was diagnosed with ultrasonography (US),
computed tomography (CT), Endoscopic retrograde cholangio-
pancreatography (ERCP), magnetic resonance imaging/magnetic
resonance cholangiopancreatography (MRI/MRCP) or hepatobil-
iary iminodiacetic acid (HIDA) scan. Pre-operative imaging with
CT or MRI of the abdomen was performed in 76% of patients.
This was done most often at the request of the surgical team as
part of the pre-operative work-up for laparoscopic cholecystec-
tomy in order to evaluate for the presence of abdominal wall
varices, a recanalized umbilical vein or concurrent hepatoma.
Screening endoscopy for evidence of portal hypertension is a valu-
able tool however was not pursued pre-operatively.
Intra-operative data recorded from the operative and anaesthe-
sia records included the following: operative time, estimated
blood loss, peri-operative transfusion requirement [within 1 week
of operative date including packed red blood cells (pRBCs), plate-
lets and fresh frozen plasma (FFP)] and the use of haemostatic
devices employed. Furthermore, conversion to open cholecystec-
tomy and reasons for doing so were also noted. Information
regarding placement of additional laparoscopic ports including
location, size and indication was obtained from the operative
record.
Post-operative features that were gathered from the medical
record included: intensive care unit (ICU) admission, length
of hospital stay, presence of acute hepatic decompensation
peri-operatively, 30-day mortality and hospital re-admission, and
post-operative infectious complications.
Anaesthesia was induced with Diprivan, fentanyl, muscle relax-
ant and maintained with inhalation anaesthetics supplemented
with muscle relaxant and fentanyl. Patients had routine monitor-
ing, which included electrocardiogram, non-invasive systemic
blood pressure, arterial oxygen saturation and end-tidal carbon
dioxide concentration. Invasive monitoring of central venous
pressure and systemic arterial pressure was determined based on
the comorbidity factors associated with cirrhosis.
An open Hasson technique via an infra-umbilical incision was
used to gain access to the peritoneal cavity after which other ports
were placed under direct visualization with transabdominal illu-
mination. Placement of the umbilical port was preferentially in
the infraumbilical position to avoid the prevalent recanalized
umbilical vein. The subxiphoid port was placed to the right of the
midline in order to avoid any potential recanalized collaterals in
the falciform ligament. If the left lateral segment appeared hyper-
trophic limiting visualization of the gallbladder neck, a fifth 5-mm
port was placed in the left upper quadrant and an assistant lifted
the left side of the liver with an instrument, such as a laparoscopic
Kittner dissector (Ethicon EndoSurgery, Cincinnati, OH, USA).
The gallbladder was decompressed as needed if dilated. Care was
taken to avoid excessive traction during cephalad retraction of the
gallbladder fundus. The triangle of Calot was dissected to identify
the cystic duct and artery. If the triangle was too inflamed, then a
prograde (dome down) dissection of the gallbladder was consid-
ered. A cholangiogram was performed as needed, but not uni-
formly. The cystic duct and artery were doubly clipped and ligated
in the usual fashion. The gallbladder was removed with an
endocatch bag though the umbilical port. Haemostasis of the
gallbladder bed was achieved by TissueLink™ or Argon beam
coagulation. All port site fascial defects were closed using an
0-Vicryl. Skin opening was closed with skin glue (e.g. Endermil).
Statistical analysis was used to calculate the mean, median and
percentages. Analysis of variance (anova) was used to evaluate
the difference in operative time. The Kruskal–Wallis test was used
to evaluate differences in blood loss and length of hospital stay.
Chi-square analysis was used to evaluate the differences in ascites
and drain placement.
Results
Of a total 282 laparoscopic cholecystectomies, 68 were attempted
in patients with liver cirrhosis. Demographics, pre-operative bio-
chemistry and Child–Pugh score are provided in Table 1. The
pre-operative indication for cholecystectomy is shown in Table 2.
Table 1 Pre-operative characteristics of patients with cirrhosis
undergoing laparoscopic cholecystectomy
Total no. of patients 68
Age, median and range in years
Gender 56 (range, 23–87)
Pre-operative lab values,
median and range
35 male, 33 female
Albumin 3.8 g/dl (1.8–4.8 g/dl)
Total bilirubin 0.9 mg/dl (0.1–13.4 mg/dl)
AST 40 U/l (15–240 U/l)
ALT 40 U/l (15–486 U/l)
Alkaline phosphatase 124 IU/l (40–537 IU/l)
INR 1.1 (0.9–2.4)
Platelet 152 K/ml (51 K–416 K/ml)
AFP 5 ng/ml (2–39 ng/ml)
Child–Pugh's classification
Class A 47 (69%)
Class B 19 (28%)
Class C 2 (3%)
Pre-op abdominal CT/MRI 54 (76.1%)
INR, international normalized ratio; ALT, alanine transaminase.
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Several patients were seen on multiple occasions by the surgical
team for refractory symptoms before undergoing cholecystec-
tomy. Differential diagnosis of these patients should include spon-
taneous peritonitis if ascites is present. The retrospective nature
of our report limits our ability to report the working differential
diagnosis in this series of patients. This was usually in an effort to
optimize their liver disease in conjunction with the hepatology
medicine team.
Intra-operative factors are shown in Table 3. Of the four
patients (6%) that were converted to an open cholecystectomy,
two of these patients had undergone prior failed attempts at
cholecystectomy.
There was no 30-day mortality or acute hepatic decompensa-
tion post-operatively in this series (Table 4). One patient devel-
oped a cystic stump bile leak that resolved with ERCP and stent
placement. Other complications included urinary tract infection
in two patients, pneumonia in one patient and one wound infec-
tion that occurred in a patient who had been converted to an open
cholecystectomy and had had a concurrent urinary tract infection.
Four patients were admitted to the ICU for post-operative moni-
toring. Median length of overall hospital stay was 1 day (range,
1–13 days). Eleven patients (16%) were re-admitted within 30
days of discharge, with the primary reasons for re-admissions
being non-surgical-related morbidity.
Based on laboratory and clinical factors, the total group of
patients were classified as Child’s class A (47 patients, 69%), class
B (19 patients, 28%), or class C (2 patients, 3%). Using anova,
significant differences according to Child–Pugh’s classification
(A, B, C) were found in operating room (OR) time (P = 0.01).
Patients with Child’s C had the longest OR time (mean = 163 min,
SD = 17 min) when compared to patients with Child’s B (mean
145 min, SD = 43 min) and Child’s A (mean = 112 min, SD =
44 min). If one examines patients with Child’s B and C collec-
tively, the results remain significant when compared to Child’s
A patients (P = 0.004). Significant differences were also observed
between the Child-Pugh’s classifications and intra-operative
blood loss (EBL) (Chi-Square = 14.5, P = 0.001). Child’s A, B and
C patients had a median blood loss of 39 ml, 158 ml, and 250 ml,
respectively. Conversion to open cholecystectomy was signifi-
cantly more common with increasing Child-Pugh’s classification
(P = 0.001). No Child’s class A patient required conversion, while
Child’s B and C patients were converted to open 16% and 50%
of the time, respectively.
Increasing Child-Pugh’s classification was significantly associ-
ated with increasing length of hospital stay (LOS) (Chi-Square =
17.6, P = 0.001). Median length of stay for patients with Child’s A,
Child’s B, and Child’s C were 1.6, 3.4, and 7 days, respectively.
If Child’s B and C patients were combined, the results remain
significant for EBL (P = 0.001) and LOS (P = 0.001).
Discussion
Patients with cirrhosis have a higher rate of developing gallstones
compared with the general population.1–5 At the advent of
laparoscopy for cholecystectomies, cirrhosis was considered a
contraindication. However, several series have since reported lap-
aroscopic cholecystectomy in the setting of cirrhosis as safe and
associated with acceptable morbidity and mortality.11–19 Most of
the series to date have originated from Asia or Europe. The present
study represents the experience at a large tertiary centre in the
United States.
In the present study, there was no mortality and only minimal
morbidity associated with laparoscopic cholecystectomy in
patients with cirrhosis. No patients developed acute liver failure
and only a small percentage (7%) required post-operative ICU
admission. Median length of stay was 1 day with all complications
and 30-day readmission non-surgical related. As one would
Table 2 Indications for laparoscopic cholecystectomy in patients
with cirrhosis
Chronic cholecystitis 31 (46%)
Symptomatic cholecystitis 15 (22%)
Gallstone pancreatitis 7 (10%)
Gallbladder mass 5 (7%)
Biliary dyskinesia 3 (4%)
Acute cholecystitis 2 (3%)
Prior acute cholecystitis 2 (3%)
Pre-operative kidney transplant, cholelithiasis 2 (3%)
Prior common bile duct stone 1 (2%)
Table 3 Intra-operative characteristics of laparoscopic cholecystec-
tomy for patients with cirrhosis
Operative time, median and range in minutes 120 min (35–229 min)
Estimated blood loss, median and range
in ml
25 ml (25–600 ml)
5th additional port placement 8/68 patients (11%)
TissueLink/argon beam coagulator 61/68 patients (90%)
Product transfusions (pRBCs, Plts, FFP) 4/68 patients (6%)
pRBC transfusion 1/68 patient (1%)
Intra-peritoneal drain placement 24/68 patients (35%)
Conversion to open 4/68 patients (6%)
pRBC, packed red blood cells.
Table 4 Post-operative course after laparoscopic cholecystecomy
for patients with cirrhosis patients
30-day mortality 0
Acute hepatic decompensation 0
Post-op bile leak 1/68 (1.5%)
Post-operative infectious complications 2 UTI, 1 pneumonia,
1 wound infection
ICU admission 4/68 (5.6%)
Length of hospital stay 1 day (1–13)
30-day re-admissions 11/68 (15.5%)
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expect, with worsening liver disease, based on increasing Child–
Pugh’s classification, laparoscopic cholecystectomy was associated
with longer operative time, more blood loss, higher conversion
rate, more ascites, longer length of stay and a high rate of 30-day
re-admission. However, in the present study, the complication
rates were not significantly different with increasing Child–Pugh’s
classification.
Puggioni and Wong (2003) performed a meta-analysis from 17
studies with a total of 351 patients, of whom 75.5% were Child’s
class A, 21.4% were Child’s class B and 1.7% were Child’s class C,
which similar ratios as seen in this series.20 Laparoscopic chole-
cystectomy was performed electively in 83% of the patients and
for emergent, acute cholecystitis in 17% of patients. The overall
morbidity after a laparoscopic cholecystectomy in cirrhotic
patients was 18.2% of patients and mortality occurred in 0.28% of
patients. Compared with non-cirrhotic patients who underwent
laparoscopic cholecystectomy, cirrhotic patients tended to have a
higher rate of acute cholecystitis (47% vs. 15%, P < 0.001), longer
operative time (98.2 min vs. 70 min, P = 0.005), higher conversion
to open rate (7.1% vs. 3.6%, P = 0.02), higher complication rate
(20.9% vs. 8%, P < 0.001) and more intra-operative bleeding
(26.4% vs. 3.1%, P < 0.001). There was no significant difference
in wound infection and mortality between cirrhotic and non-
cirrhotic patients. In patients with cirrhosis who underwent lap-
aroscopic versus open cholecystectomy, the laparoscopic group
had a shorter operative time (123.3 vs. 150.4 min, P = 0.04), less
blood loss (113 vs. 425.5 ml, P = 0.015) and shorter length of
hospital stay (6 vs. 12.2 days, P < 0.001). There was no difference
in morbidity (9.25%–15%), mortality (0–4.76%) or wound infec-
tion rates (0–0.13%). The authors concluded that although
laparoscopic cholecystectomy in patients with cirrhosis was asso-
ciated with higher morbidity compared with non-cirrhotic
patients, the laparoscopic approach was also associated with
shorter operative time, less blood loss and shorter length of
hospital stay in patients with cirrhosis with symptomatic biliary
disease compared with the open approach. Given the small
number of patients with Child’s class C cirrhosis, no conclusions
could be made in this patient population.
In Puggioni and Wong’s meta-analysis, laparoscopic cholecys-
tectomies were performed for emergencies in 17% of patients
with cirrhosis who presented with biliary disease.20 This study
series differs significantly as acute cholecystitis was present in
only 3% of patients. For patients with advanced cirrhosis based
on the Child–Pugh’s score and acute cholecystitis, ICU admis-
sion for monitoring and observation and conservative manage-
ment with fluid rescuscitation and intravenous antibiotics should
be the initial step of management. If their clinical status worsens,
coagulopathy should be corrected immediately with fresh frozen
plasma and vitamin K and a cholecystectomy performed. One
should also consider the selective use of a decompression chole-
cystostomy tube in patients who may not tolerate general anaes-
thesia.21 If there are concerns regarding collateral vessels in the
gallbladder bed or in the hilum, then a laparoscopic subtotal
cholecystectomy may be considered, although this was not uti-
lized in our series.22–24
Pre-operative imaging, such as a CT scan or MRI, was obtained
in 76% of patients. This provided invaluable information regard-
ing the presence or absence of abdominal varices which, in turn,
was used to plan the port placement during the operation. In
addition, it was used to screen for the potential presence of con-
current hepatoma, which might change the operative plan and has
become part of the practice.
The TissueLink electrocautery or argon beam coagulator was
used in 90% of patients in this series. Whether or not this practice
directly impacts upon blood loss or need for peri-operative trans-
fusions is not clear. However, the use of cautery (normal or Tis-
suelink) near the liver hilum and, most importantly, the bile duct,
should be avoided if possible in order to prevent potential thermal
injury. Tissuelink cautery may penetrate the liver parenchyma and
therefore should not be used in hilum. The majority of techniques
reported in the literature in laparoscopic cholecystectomy employ
some form of haemostatic device besides the traditional hook
cautery in order to dissect the gallbladder of the gallbladder fossa.
This has helped minimize bleeding, which is a major cause of
complications after laparoscopic cholecystectomy in patients with
cirrhosis patients. In the meta-analysis by Puggioni and Wong
(2003), 4.3% of patients developed post-operative liver bleeding
and 2.8% of patients developed post-operative intra-abdominal
haematoma. In the present study, the use of topical sealants (col-
lagen fleece, cyano-acrylate and fibrin sealants) was not required
but the use of the TissueLink or argon beam was crucial and
sufficient in achieving haemostasis at the gallbladder fossa after
removal of the gallbladder.
In the present study, an additional 5th port was placed in the
left upper quadrant in 10% of the patients to help elevate the
left lateral segment, which was hypertrophied and heavy in these
patients with cirrhosis. This manoeuver helps prevent excessive
traction on the gallbladder and prevent potential bleeding
(Table 5). Palanivelu et al. (2006) placed additional ports in
53.6% of their patients to improve exposure to the hilum by
either retracting the duodenum or omentum downward or to
lift the liver upward.22
In the present study, only two patients (3%) who underwent
cholecystectomy were Child’s class C cirrhotics. In fact, there has
been very little reported regarding this subject. In the meta-
analysis by Puggioni et al. (2003), only 1.7% of the patients were
Child’s class C cirrhotics.20 Curro et al. (2005) reported a 50%
mortality (due to severe liver failure and sepsis) and 75% morbid-
ity rate, with double the length of hospital stay in only 4 Child’s
class C cirrhotic patients who undergo laparoscopic cholecystec-
tomy compared with patients with Child’s class A or B cirrhosis.18
This study was also limited by the number of Childs C cirrhotic
patients reported; however, they recommended that cholecys-
tectomy should only be entertained in Child’s class C cirrhotic
patients who develop acute cholecystitis that does not respond
to conservative medical management. Under non-emergent
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situations, patients with Child’s class C cirrhosis should be
medically managed and downstaged before undergoing a chole-
cystectomy. Liver transplantation evaluation and listing before
cholecystectomy in Child’s B or C patients is recommended. For-
tunately, none of the patients in the present study suffered acute
decompensation necessitating organ transplantation. Alter-
natively, Schlenker et al. (2006) recommended endoscopic gall-
bladder stenting as a therapeutic option in high-risk cirrhotic
patients.24 Gallbladder stenting was performed in 23 patients, 38%
of whom were diagnosed with acute cholecystitis. Twenty of the 23
patients (87%) remained asymptomatic until transplantion, death
or conclusion of the study period.
Conclusion
Laparoscopic cholecystectomy in patients with cirrhosis is feasible
with no mortality and low morbidity rates in experienced hands.
The present study demonstrates that laparoscopic cholecystec-
tomy is safe for Childs A however Childs B patients should be
considered cautiously and Childs C should be approached only as
a last attempt in life-threatening and failing medical management.
To minimize the morbidity and mortality, the study proposes
a number of recommendations for the pre-operative, intra-
operative and post-operative approach to laparoscopic cholecys-
tetomy in this patient population.
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